Group comparison by median changes in CDAI between indicated time points for patients with an initial score less or greater than 300
| Time point (months) | ||||
|---|---|---|---|---|
| 0–1 | 1–2 | 2–3 | 3–6 | |
| CDAI <300 | ||||
| Azathioprine | 97 | 3 | −10 | 12 |
| MMF | 120 | −16 | 34 | −45 |
| p Value | 0.4298 | 0.2542 | 0.1302 | 0.1047 |
| CDAI >300 | ||||
| Azathioprine | 117 | −37 | 11 | 42 |
| MMF | 265 | 0 | 8 | 3 |
| p Value | 0.0125 | 0.1985 | 0.8053 | 0.2392 |
p values are based on two sample Wilcoxon tests.
Positive changes indicate decreases in CDAI scores.